dapt trial summary - Axtarish в Google
Interpretation: The results of the DAPT trial indicate that prolonged duration of DAPT up to 30 months following index PCI with a DES results in lower stent thrombosis and recurrent MIs compared with a 12-month duration of DAPT , although bleeding and all-cause mortality were higher with prolonged therapy.
16 февр. 2018 г.
16 нояб. 2014 г. · Dual antiplatelet therapy beyond 1 year after placement of a drug-eluting stent, as compared with aspirin therapy alone, significantly reduced the risks of ...
The DAPT study evaluated the optimal duration of dual antiplatelet therapy after percutaneous coronary intervention, with implications for clinical ...
Continued DAPT (totaling 30 months) reduces the rate of stent thrombosis and death, MI, or stroke at the cost of increased bleeding.
8 мая 2024 г. · ULTIMATE-DAPT Trial · Assuming a 3.0% rate of clinically relevant bleeding, 3400 patients provided 80% power to detect a 50% reduction in ...
Продолжительность: 2:18
Опубликовано: 11 дек. 2014 г.
4 янв. 2024 г. · The STOPDAPT-2 trial showed that 1-month DAPT was superior to 12-month DAPT at preventing net adverse ischemic events.
randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous ...
Compared with DAPT for six to 12 months, extending DAPT for more than 12 months may reduce the risk of MI and probable or definite stent thrombosis but increase ...
This review provides a comprehensive summary of the major trials that have informed current DAPT strategies, puts into context recent trials driving a shift ...
Novbeti >

Ростовская обл. -  - 
Axtarisha Qayit
Anarim.Az


Anarim.Az

Sayt Rehberliyi ile Elaqe

Saytdan Istifade Qaydalari

Anarim.Az 2004-2023